![Context Therapeutics](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2021/11/Context-Therapeutics.jpg?resize=735%2C400&ssl=1)
Context Therapeutics Takes Bold Step with IND Submission for Groundbreaking Cancer Therapy
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) recently announced its submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for CTIM-76. This …
Context Therapeutics Takes Bold Step with IND Submission for Groundbreaking Cancer Therapy Read More